AlphaYouDK
Insider selling
Daphne Karydas sold $86K of Mineralys Therapeutics, Inc. (MLYS) stock
Daphne Karydas, Dir of Mineralys Therapeutics, Inc. (MLYS), sold 3,000 shares of MLYS stock worth $86K, per an SEC Form 4 filed Sep 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 15, 2026, 2 days before it was made public.
MLYS has moved +1.7% since the trade date, from $28.91 to $29.40 (Sep 22, 2026 close).
- Traded
- Sep 15, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 2 days
- Price since
- +1.7%
- Role
- Dir
- Source
- SEC Form 4
More MLYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.